© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chlorthalidone shows up as a white or slightly off-white crystalline powder. The formula is C14H11ClN2O4S, reflecting its structure as a monosulfamyl diuretic. This compound works to help control hypertension and fluid retention in a variety of medical settings. Often grouped among thiazide-like diuretics, it is valued for its robust action in reducing blood pressure by acting on the kidneys to remove excess salt and water from the body. Chlorthalidone has found regular use in both primary care and hospital settings. Healthcare providers select this raw material for its proven track record in cardiovascular health, with guidelines highlighting its role in long-term blood pressure control.
Most batches appear in solid form, either as flakes or as a fine, pure powder. Some manufacturers prepare it in pearls or a crystalline solid. It dissolves sparingly in water but better in acetone, methanol, and ethanol. The melting point usually settles near 220–230°C, reflecting its stability under moderate heat. Chlorthalidone’s density sits close to 1.43 g/cm³, and the molecular mass measures 338.76 g/mol. Many medical suppliers package this raw material as a stable, odorless solid for simple weighing and mixing in compounding rooms. Pharmacies that handle this compound often prefer the powder or crystalline format for accuracy in dosing and mixing, especially when preparing compounded medications.
A look at the chemical skeleton reveals a benzene ring linked to a sulfonamide group and a phthalimidine structure. This balance of functional groups helps explain chlorthalidone’s mechanism and interactions. The chlorine atom at the fourth position of the benzene ring modifies its reactivity, giving rise to the product’s observed therapeutic properties. The molecular formula C14H11ClN2O4S accounts for every functional group present, including the essential sulfonamide, which helps block sodium reabsorption in the kidneys. Structural stability supports long shelf life and broad transport, so hospitals and clinics keep it on hand even with variable supply chains.
Drug-grade chlorthalidone typically exceeds 98% purity according to compendial standards such as USP or EP. The accepted specifications confirm absence of hazardous volatile organics, confirmation by HPLC, and compliance with stated impurity limits for safe patient use. The material is usually stored dry, protected from moisture and light, as degradation may affect potency. Chlorthalidone is classified under the Harmonized System (HS) Code 2935009090, which covers sulfonamides including related medicinals. Importers and exporters use this code to comply with regulatory obligations when moving the product internationally. Regulatory labeling must reflect chemical identity, weight, batch number, and production date to satisfy both inspectors and pharmacists.
Buyers can source chlorthalidone as solid powder, crystalline material, or, less often, in solution. Each physical form comes with safety instructions applicable to raw chemicals. Inhalation or direct skin contact should be avoided; laboratories enforce PPE use like gloves and N95 masks during weighing, blending, or transfer. Eyes and mucous membranes require extra protection, as the raw chemical can cause irritation. Shipping containers usually feature tamper-proof seals with hazard labels according to GHS. Storage areas keep the material in original, tightly closed bottles to avoid contamination and moisture uptake, which could lead to clumping or diminished potency. I’ve often seen supply chain teams conduct routine inventory and temperature spot checks on these chemicals to guarantee quality for end use in compounding and finished pharmaceuticals.
The regulatory data point to toxicity if the raw chemical is ingested or inhaled outside of prescribed use. Employees in chemical supply or pharmaceuticals must handle chlorthalidone in well-ventilated environments. Spills can generate dust, so lab managers stress use of HEPA vacuums rather than sweeping to avoid particle dispersion. The compound does not present the flammability risks found in some solvents, but responsible handlers always review safety data sheets before opening a new batch. I’ve worked with compounding teams who rely on such guidance for every new delivery, ensuring hazardous reactions or exposures do not happen in busy pharmacy areas.
Safe handling relies on clear labeling, batch tracking, and standardized ventilation. Most facilities use lockable cabinets for controlled access, with restricted use to trained staff. Implementation of digital tracking—scanning barcodes or QR codes—helps prevent dosage errors and ensures quick recalls if a contaminated batch ever shows up. Training staff with regular drills on spill response minimizes risk and lowers incident rates. Waste chlorthalidone goes through approved disposal channels to limit environmental impact, for instance, by sending it through hazardous waste handlers rather than regular trash. This attention to laws and respect for chemical hazards supports long-term worker health and public safety. In the sphere of pharmaceutical logistics, I find that working closely with environmental safety officers, training and compliance teams, and responsible waste contractors secures a safe journey for chlorthalidone from warehouse to treatment room, preventing harm and ensuring reliable patient access to this essential medicine.
